Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 221 results for "Tecfidera Treated Patients"

Biogen : Tecfidera Data Reinforce Efficacy For Newly-Diagnosed...

Biogen (BIIB: Quote) announced new data that continue to support Tecfidera or dimethyl fumarate as an effective, long-term treatment for people who are living with relapsing forms of multiple sclerosis or MS. The data show Tecfidera significantly ..., 1 day ago
New Data Released for Tecfidera in Multiple Sclerosis Monthly Prescribing Reference, 21 hours ago

First Case of Fumarate-Linked PML in Nonlymphopenic Patient

Dutch clinicians report what they believe is the first case of progressive multifocal leukoencephalopathy (PML) after treatment with compounded dimethyl fumarate (DMF) in a patient without severe lymphocytopenia. This situation was "previously ...
 Dermatology Online Journal1 week ago MS Drug Linked to Two Cases of PML  Monthly Prescribing Reference1 week ago Dimethyl Fumarate Linked to Development of PML  Physician's Briefing1 week ago Ingredient in MS, Psoriasis Drugs Linked to Two Deadly Brain Infections  US News & World Report1 week ago

Patient Dies Using Drug With Active Ingredients Like Biogen (BIIB)'s Tecfidera 4/13/2015

April 9, 2015 By Mark Terry , Breaking News Staff Dutch physicians published a case study today in The New England Journal of Medicine describing a patient who died from a reaction to a common ingredient in treatments for ...
 ClinicSpace6 days ago Death Possibly Linked to Biogen (BIIB) Tecfidera "No Cause for Alarm," Says Analyst 4/10/2015  ClinicSpace1 week ago Death Possibly Linked to Biogen Tecfidera "No Cause for Alarm," Says Analyst  BioSpace1 week ago MS Specialist Picks Biogen Idec???s Tecfidera and Plegridy, Teva???s Laquinimod: Analyst  BioSpace1 month ago

Multiple Sclerosis (MS)

Medical Author: Danette C. Taylor, DO, MS, FACN Dr. Taylor has a passion for treating patients as individuals. In practice since 1994, she has a wide range of experience in treating patients with many types of movement disorders and ...
 MedicineNet.com1 month ago

Biogen Alzheimer's Drug Impresses in Early Study

A Biogen Idec Inc. drug that targets plaque buildup in the brain slowed cognitive decline in patients with early and mild forms of Alzheimer's disease in a small, early-stage study, lifting the company's stock to all-time highs and adding to the ...
 Wall Street Journal UK1 month ago Biogen's Alzheimer's Drug Impresses in Early Trial — 2nd Update  iMarketReports1 month ago Biogen's future: Bigger bets on CNS, smaller name  FierceBiotech4 weeks ago Company Update (NASDAQ:BIIB): Here's who's getting rich off of Biogen Idec's success  Jutia Group1 month ago

New oral treatment for multiple sclerosis approved for use in Canada

Linda Hoang, CTV Edmonton Published Tuesday, May 7, 2013 4:07PM MDT Last Updated Tuesday, May 7, 2013 6:06PM MDT A new oral treatment for those living with multiple sclerosis has been approved for use in Canada. Tecfidera is an oral ...
 CTV News1 month ago

U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R)

(GLOBE NEWSWIRE) -- Forward Pharma A/S ( Nasdaq:FWP ) (the "Company") announced today that an interference was declared by the Patent Trial and Appeal Board (PTAB) on April 13, 2015 between the Company's patent application 11/576,871 (the "'871 ...
 Wall Street Business Network6 days ago Forward Pharma A/S : U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of...  4 Traders6 days ago Global Oil and Gas Cloud Applications Market 2015-2019: Data Analytics, CRM, ECM, Collaboration, HCM, ERP, Project Management, SCM, GRC, Core Industry Applications  Benzinga.com6 days ago KegWorks Attends 2015 CBC to Unveil New Product Line  Financial Content6 days ago

Could This Study Help Lead to a Cure for Select Multiple Sclerosis Patients?

Source: National Multiple Sclerosis Society, Facebook For a disease that affects 2.5 million people around the globe and more than 400,000 people in the United States, it's a shame that so little is known about multiple sclerosis despite the amount ...
 Nasdaq1 month ago

Alkermes heads to Phase III with a schizophrenia drug designed to spare the waistline

Alkermes ($ALKS) unveiled more positive data for a schizophrenia drug the company believes can treat the disease without spurring weight gain, beating a path to late-stage development. The treatment, ALKS 3831, combines the common antipsychotic ...
 FierceBiotech2 weeks ago Alkermes - The Underappreciated Biopharmaceutical  Seeking Alpha1 week ago Alkermes ditches some Elan remnants and bears down on its pipeline  FierceBiotech1 month ago

Gilead warns of fatal reaction to Sovaldi, Harvoni and heart drug

9 patients taking hep C drugs with amiodarone develop bradycardia, 1 dies and 3 need pacemakers Share Tools Gilead Sciences' ($GILD) superselling hepatitis C drugs have hit a speed bump after 9 patients taking either Harvoni or Sovaldi, as ...
 FiercePharma4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less